Multiple Toll-like receptors

Class

Bacterial-based innate/adaptive immune activator (Decoy platform, multi-TLR agonist)

Pathway

innate immune activation and antigen presentation

Notes

original target text: Multiple Toll-like receptors (innate immune pattern-recognition receptors, engaged via systemically administered attenuated decoy bacteria)

Toll-like receptors (TLRs) are a family of pattern-recognition receptors found on and within immune cells such as dendritic cells, macrophages, and B cells. They evolved to detect conserved molecular signatures common to microbes—components of bacterial cell walls, flagellar proteins, microbial nucleic acids—and, once engaged, trigger intracellular signaling that activates transcription factors controlling inflammatory and antiviral gene programs. This activation drives cytokine and interferon release and upregulates the machinery immune cells use to display antigens, linking rapid pathogen detection to the slower, more specific adaptive immune response involving T cells. A single TLR agonist typically produces a narrow, short-lived signal, so therapeutic strategies increasingly aim to engage several TLRs at once, approximating the broad, multi-receptor stimulation that occurs during a natural infection. One approach uses attenuated, non-disease-causing bacteria given systemically as a delivery vehicle: these organisms retain many native TLR ligands and can activate several receptor pathways simultaneously within the same immune cells. This general mechanism is relevant wherever stronger innate immune activation and improved antigen presentation are therapeutic goals, including cancer immunotherapy, where reshaping tumors that evade immune recognition is a central aim, and in vaccine adjuvant design, where amplifying antigen-specific responses improves durability and strength of protection.